Evaluation of the role of fMLF chemotaxic peptide receptors in umbilical cord blood granulocytes from newborns at risk of infectious inflammatory diseases

Bulletin of Experimental Biology and Medicine

Volumn 145, Issue 4, 2008, Pages 452-456

  Safronova, V G ^a   Matveeva, N K ^b   Mal'tseva, V N ^a   Bondar', O E ^b   Van'ko, L V ^b   Sukhikh, G T ^b  

^a INSTITUTE OF CELL BIOPHYSICS   (Russian Federation)

^b RESEARCH CENTER OF OBSTETRICS   (Russian Federation)

Author keywords

fMLF; Granulocytes; High and low affinity receptors; Newborns; Respiratory burst

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; REACTIVE OXYGEN METABOLITE;

ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; GRANULOCYTE; HIGH RISK INFANT; HUMAN; HUMAN CELL; INFLAMMATION; NEWBORN; NEWBORN PERIOD; PREGNANCY COMPLICATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY BURST; UMBILICAL CORD BLOOD;

CASE-CONTROL STUDIES; CELLS, CULTURED; COMMUNICABLE DISEASES; FEMALE; FETAL BLOOD; GRANULOCYTES; HUMANS; INFANT, NEWBORN; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; OLIGOPEPTIDES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RECEPTORS, FORMYL PEPTIDE; RISK FACTORS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

BACTERIA (MICROORGANISMS);

EID: 55649096174     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-008-0116-4     Document Type: Article

References (15)

1. V. L. Katanaev, Biokhimiya, 66, 437-456 (2001).
2. V. G. Safronova, A. G. Gabdulkhakova, V. N. Mal'tseva, et al., Biol. Membrany, 23, 171-181 (2006).
3. V. G. Safronova, N. K. Matveeva, V. N. Mal'tseva, et al., Byull. Eksp. Biol. Med., 142, No. 9, 304-308 (2006).
4. B. Heit, S. Tavener, E. Raharjo, and P. Kubes, J. Cell. Biol., 159, No. 1, 91-102 (2002).
5. F. Ishikawa and S. Miyazaki, Arch. Immunol. Ther. Exp. (Warsz.), 53, No. 3, 226-233 (2005).
6. H. Komatsu, K. Tsukimori, K. Hata, et al., Early Hum. Dev., 65, No. 1, 11-19 (2001).
7. M. C. Lavigne, P. M. Murphy, T. L. Leto, and J. L. Gao, Cell. Immunol., 218, Nos. 1-2, 7-12 (2002).
8. O. Levy, Nat. Rev. Immunol., 7, No. 5, 379-390 (2007).
9. C. Nagano, A. Azuma, H. Ishiyama, et al., J. Pharmacol. Exp. Ther., 297, No. 1, 388-394 (2001).
10. M.-H. Paclet, C. Davis, P. Kotsonis, et al., Biochem. J., 377, Pt. 2, 469-477 (2004).
11. G. S. Tjabringa, D. K. Ninaber, J. W. Drijfhout, et al., Int. Arch. Allergy Immunol., 140, No. 2, 103-112 (2006).
12. S. E. Van Compernolle, K. L. Clark, K. A. Rummel, and S. C. Todd, J. Immunol., 171, No. 4, 2050-2056 (2003).
13. S. F. van Eeden, M. E. Klut, B. A. Walker, and J. C. Hogg, J. Immunol. Methods, 232, Nos. 1-2, 23-43 (1999).
14. A. Viswanathan, R. G. Painter, N. A. Lanson Jr., and G. Wang, Stem Cells, 25, No. 5, 1263-1269 (2007).
15. Y. Zhou, K. Bian, Y. Le, et al., J. Natl. Cancer Inst., 97, No. 11, 823-835 (2005).